XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jul. 31, 2025
Apr. 30, 2025
Current assets:    
Cash and cash equivalents $ 10,325 $ 9,785
Accounts receivable, net 9,474 11,204
Prepaid expenses and other current assets 1,215 1,369
Total current assets 21,014 22,358
Operating lease right-of-use assets, net 4,771 5,080
Property and equipment, net 4,230 4,375
Other long-term assets 196 196
Goodwill 335 335
Total assets 30,546 32,344
Current liabilities:    
Accounts payable 4,845 4,248
Accrued liabilities 1,801 2,556
Current portion of operating lease liabilities 1,506 1,471
Other current liability 116 135
Deferred revenue 14,430 15,443
Total current liabilities 22,698 23,853
Non-current operating lease liabilities 4,244 4,634
Other non-current liabilities 66 85
Total liabilities 27,008 28,572
Stockholders’ equity:    
Common stock, $.001 par value; 200,000,000 shares authorized; 13,908,754 and 13,897,503 shares issued; and 13,788,421 and 13,777,170 outstanding as of July 31, 2025 and April 30, 2025, respectively 14 14
Treasury stock, at cost (708) (708)
Additional paid-in capital 84,560 84,358
Accumulated deficit (80,358) (79,892)
Total stockholders’ equity attributable to Champions Oncology, Inc. 3,508 3,772
Noncontrolling interest 30 0
Total stockholders' equity 3,538 3,772
Total liabilities and stockholders’ equity $ 30,546 $ 32,344